Dr Linehan reported receiving royalties from Guilford Press for books that she has written on dialectical behavior therapy, royalties for training materials from Behavioral Tech LLC, and compensation for dialectical behavior therapy workshops, online programs, and books. Dr Harned reported receiving grant support and personal fees from the Behavioral Tech LLC outside the work represented in this article. Dr Asarnow reported receiving grant support and support from the Substance Abuse and Mental Health Services Administration, American Foundation for Suicide Prevention, American Psychological Association, and the Society of Clinical Child and Adolescent Psychology and serving as a consultant on quality improvement interventions for depression and suicidal/self-harm behavior. On the basis of the criteria of 2 independent trials supporting efficacy, results support DBT as the first well-established, empirically supported treatment for decreasing repeated suicide attempts and self-harm in youths.Ĭ Identifier: NCT01528020.Ĭonflict of Interest Disclosures: Drs McCauley, Berk, Asarnow, Adrian, Cohen, Korslund, Hughes, and Avina reported receiving grant support from the National Institute of Mental Health (NIMH), National Institutes of Health.
#October 2013 teen suicide band trial
The results of this trial support the efficacy of DBT for reducing self-harm and suicide attempts in highly suicidal self-harming adolescents. Treatment completion rates were higher for DBT (75.6%) than for IGST (55.2%), but pattern-mixture models indicated that this difference did not informatively affect outcomes. The advantage of DBT decreased, with no statistically significant between-group differences from 6 to 12 months (OR, 0.65 95% CI, 0.12-3.36 P =. Rates of self-harm decreased through 1-year follow-up. Significant advantages were found for DBT on all primary outcomes after treatment: suicide attempts (65 of 72 receiving DBT vs 51 of 65 receiving IGST with no suicide attempts odds ratio, 0.30 95% CI, 0.10-0.91), nonsuicidal self-injury (41 of 72 receiving DBT vs 26 of 65 receiving IGST with no self-injury OR, 0.32 95% CI, 0.13-0.70), and self-harm (39 of 72 receiving DBT vs 24 of 65 receiving IGST with no self-harm OR, 0.33 95% CI, 0.14-0.78). Both groups had weekly individual and group psychotherapy, therapist consultation meetings, and parent contact as needed.Ī priori planned outcomes were suicide attempts, nonsuicidal self-injury, and total self-harm assessed using the Suicide Attempt Self-Injury Interview.Ī total of 173 adolescents (163 female and 97 white mean age, 14.89 years) were studied. Study participants were randomly assigned to DBT or IGST. Participants were followed up for 1 year. Adaptive randomization balanced participants across conditions within sites based on age, number of prior suicide attempts, and psychotropic medication use. A total of 173 participants (pool of 195 22 withdrew or were excluded) 12 to 18 years of age with a prior lifetime suicide attempt (≥3 prior self-harm episodes, suicidal ideation, or emotional dysregulation) were studied. This randomized clinical trial was conducted from January 1, 2012, through August 31, 2014, at 4 academic medical centers. To evaluate the efficacy of dialectical behavior therapy (DBT) compared with individual and group supportive therapy (IGST) for reducing suicide attempts, nonsuicidal self-injury, and overall self-harm among high-risk youths. Suicide is a leading cause of death among 10- to 24-year-old individuals in the United States evidence on effective treatment for adolescents who engage in suicidal and self-harm behaviors is limited.
0 kommentar(er)
